Association between dose reduction of renin-angiotensin-aldosterone system inhibitors before coronary artery angiography and acute kidney injury: a propensity score-matched study

References

• McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103(5):368–375.
   PubMed Web of Science ®Google Scholar
• Thakar CV, Christianson A, Freyberg R, et al. Incidence and outcomes of acute kidney injury in intensive care units: a veterans administration study. Crit Care Med. 2009;37(9):2552–2558.
   PubMed Web of Science ®Google Scholar
• Jabara R, Gadesam RR, Pendyala LK, et al. Impact of the definition utilized on the rate of Contrast-Induced nephropathy in percutaneous coronary intervention. Am J Cardiol. 2009;103(12):1657–1662.
   PubMed Web of Science ®Google Scholar
• James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6(1):37–43.
   PubMed Web of Science ®Google Scholar
• Suh SH, Kim CS, Choi JS, et al. Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes. Yonsei Med J. 2013;54(4):965–972.
   PubMed Web of Science ®Google Scholar
• Plataki M, Kashani K, Cabello-Garza J, et al. Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol. 2011;6(7):1744–1751.
   PubMed Web of Science ®Google Scholar
• Bainey KR, Rahim S, Etherington K, et al. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: results from the angiotensin converting enzyme inhibitor/angiotensin receptor bloc. Am Heart J. 2015;170(1):110–116.
   PubMed Web of Science ®Google Scholar
• Wolak T, Aliev E, Rogachev B, et al. Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study. Isr Med Assoc J. 2013;15(11):682–687.
   PubMed Web of Science ®Google Scholar
• Penny W, Andrew M, Tomlinson LA, et al. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis penny. BMJ Open. 2017;7(4):e012674.
   PubMed Web of Science ®Google Scholar
• Rosenstock JL, Bruno R, Kim JK, et al. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol. 2008;40(3):749–755.
   PubMed Web of Science ®Google Scholar
• Sanders G, Coeytaux R, Dolor R, et al. Angiotensin-Converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), and direct renin inhibitors for treating essential hypertension: an update. Angiotensin-Converting enzym. Inhib. (ACEIs), angiotensin II recept. Antagon. (ARBs), direct renin inhib. Treat. Essent Hypertens An Updat. 2011;(34):368.
   Google Scholar
• Takeuchi M, Ogura M, Minoura T, et al. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus other classes of glucose-lowering medications on renal outcome in type 2 diabetes. Mayo Clin Proc. 2020;95(2):265–273.
   PubMed Web of Science ®Google Scholar
• Ide K, Fujiwara T, Shimada N, et al. Influence of acetaminophen on renal function: a longitudinal descriptive study using a real-world database. Int Urol Nephrol. 2021;53(1):129–135.
   PubMed Web of Science ®Google Scholar
• Williams LMS, Walker GR, Loewenherz JW, et al. Association of contrast and acute kidney injury in the critically ill: a propensity-matched study. Chest. 2020;157(4):866–876.
   PubMed Web of Science ®Google Scholar
• Rodrigo M, Ana Paula de F, Alessandra MVR, et al. Defined daily dose (DDD) and its potential use in clinical trials of resistant hypertension. Int J Cardiol. 2016;202:515–516.
   PubMed Web of Science ®Google Scholar
• Teng L, Xin H, Blix H, et al. Review of the use of defined daily dose concept in drug utilisation research in China. Pharmacoepidemiol Drug Saf. 2012;21(10):1118–1124.
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.
   PubMed Web of Science ®Google Scholar
• Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27(12):2037–2049.
   PubMed Web of Science ®Google Scholar
• Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–3107.
   PubMed Web of Science ®Google Scholar
• Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. J Am Med Assoc. 2017;318(13):1241–1249.
   PubMed Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184.
   PubMedGoogle Scholar
• Normand SLT, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–398.
   PubMed Web of Science ®Google Scholar
• Frohlich ED. Angiotensin convertin enzyme inhibitors. Present and future. Hypertension. 1989;13(5_supplement):125–130.
   Google Scholar
• Li B, Yao J, Kawamura K, et al. Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB. Kidney Int. 2004;66(5):1939–1948.
   PubMed Web of Science ®Google Scholar
• Deray G, Martinez F, Cacoub P, et al. A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol. 1990;10(4):316–322.
   PubMed Web of Science ®Google Scholar
• Weisberg LS, Kurnik PB, Kurnik BRC. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int. 1992;41(5):1408–1415.
   PubMed Web of Science ®Google Scholar
• Idé J-M, Lancelot E, Pines E, et al. Prophylaxis of iodinated contrast Media-Induced nephropathy: a pharmacological point of view. Invest Radiol. 2004;39(3):155–170.
   PubMed Web of Science ®Google Scholar
• Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2004;93(1):c29–c34.
   Google Scholar
• Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162(3):329–336.
   PubMedGoogle Scholar
• Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008;3(1):288–296.
   PubMed Web of Science ®Google Scholar
• Gorelik Y, Khamaisi M, Abassi Z, et al. Renal functional recovery among inpatients: a plausible marker of reduced renal functional reserve. Clin Exp Pharmacol Physiol. 2021;48(12):1724–1727.
   PubMed Web of Science ®Google Scholar
• Day AG. Why the propensity for propensity scores? Crit Care Med. 2015;43(9):2024–2026.
   PubMed Web of Science ®Google Scholar
• Kitsios GD, Dahabreh IJ, Callahan S, et al. Can We trust observational studies using propensity scores in the critical care literature? A systematic comparison with randomized clinical trials. Crit Care Med. 2015;43(9):1870–1879.
   PubMed Web of Science ®Google Scholar
• Stuart EA. Developing practical recommendations for the use of propensity scores: discussion of “a critical appraisal of propensity score matching in the medical literature between 1996 and 2003” by peter austin, statistics in medicine. Statist Med. 2008;27(12):2062–2065.
   PubMed Web of Science ®Google Scholar
• McDonald JS, McDonald RJ, Williamson EE, et al. Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med. 2017;43(6):774–784.
   PubMed Web of Science ®Google Scholar
• Jurado-Román A, Hernández-Hernández F, García-Tejada J, et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol. 2015;115(9):1174–1178.
   PubMed Web of Science ®Google Scholar
• Putzu A, Boscolo Berto M, Belletti A, et al. Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: a systematic review and meta-analysis of randomized trials. JACC Cardiovasc Interv. 2017;10(4):355–363.
   PubMed Web of Science ®Google Scholar
• Wheeler DC, Stefansson BV, Batiushin M, et al. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol Dial Transplant. 2020;35(10):1700–1711.
   PubMed Web of Science ®Google Scholar